Association of hormone replacement therapy and carotid wall thickness in women with and without diabetes

Diabetes Care

Volumn 21, Issue 11, 1998, Pages 1790-1796

  Dubuisson, Julie T ^a   Wagenknecht, Lynne E ^a   D'Agostino Jr , Ralph B ^a   Haffner, Steven M ^b   Rewers, Marian ^c   Saad, Mohammed F ^d   Laws, Ami ^e   Herrington, David M ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN;

ADULT; AGED; ARTERY WALL; ARTICLE; ATHEROSCLEROSIS; CAROTID ARTERY OBSTRUCTION; FEMALE; HORMONE SUBSTITUTION; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INTIMA; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTMENOPAUSE; TUNICA MEDIA;

ADULT; AFRICAN AMERICANS; AGED; ARTERIOSCLEROSIS; CAROTID ARTERIES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CORONARY DISEASE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; ESTROGEN REPLACEMENT THERAPY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HISPANIC AMERICANS; HUMANS; HYPERTENSION; INSULIN RESISTANCE; MIDDLE AGED; POSTMENOPAUSE; PREVALENCE; RISK FACTORS;

EID: 0031755624     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.21.11.1790     Document Type: Article

References (41)

1. Stampfer MJ, Colditz GA, Willett WC, Manson JE, Rosner B, Speizer FE, Hennekens CH: Postmenopausal estrogen therapy and cardiovascular disease: ten year follow-up from the Nurses' Health Study. N Engl J Med 325:756-762, 1991
2. Sullivan JM, Vander Zwaag R, Hughes JP, Maddock V Kroetz FW, Ramanathan KB, Mirvis DM: Estrogen replacement and coronary artery disease: effect on survival in postmenopausal women. Arch Intern Med 150:2557-2562, 1990
3. Grady D, Rubin SM, Petitti DB, Fox CS, Black D, Ettinger B, Ernster VL, Cummings SR: Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 117:1016-1037, 1992
4. Folsom AR, Mink PJ, Sellers TA, Hong C-P, Zheng W, Potter JD: Hormonal replacement therapy and morbidity and mortality in a prospective study of postmenopausal women. Am J Public Health 85: 128-132, 1995
5. Henderson BE, Paganini-Hill A, Ross RK. Decreased mortality in users of estrogen replacement therapy. Arch Intern Med 151:75-78, 1991
6. Bush TL, Barrett-Connor E, Cowan LD, Criqui MH, Wallace RB, Suchindran CM, Tyroler HA, Rifkind BM: Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. Circulation 75:1102-1109, 1987
7. The Writing Group for the PEPI Trial: Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. JAMA 273:199-208, 1995
8. Grodstein F, Stampfer MJ, Manson JE, Colditz GA, Willett WC, Rosner B, Speizer FE, Hennekens CH: Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med 335:453-461, 1996
9. Kannel WB, McGee DL: Diabetes and cardiovascular disease: the Framingham Study. JAMA 241:2035-2038, 1979
10. Barrett-Connor E, Orchard T: Diabetes and heart disease. In Diabetes in America. Harris MI, Hamman RF, Eds. Bethesda, MD, National Institutes of Health, 1985, p. 1-41 (NIH publ. no. 85-1468)
11. Barrett-Connor E, Cohn BA, Wingard DL, Edelstein SL: Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? JAMA 265:627-631, 1991
12. Kannel WB: Lipid, diabetes and coronary heart disease: insights from the Framingham Study. Am Heart J 110:1100-1107, 1985
13. Bierman EL: Atherogenesis in diabetes. Arterioscler Thromb 12:647-656, 1992
14. O'Leary DH, Polak JF, Kronmal RA, Savage PJ, Borboni NO, Kittner SJ, Tracy R, Gardin JM, Price TR, Furberg CD: Thickening of the carotid wall: a marker for atherosclerosis in the elderly? Stroke 27:224-231, 1996
15. Crouse JR III: Carotid and coronary atherosclerosis: what are the connections? Post-grad Med 90:175-179, 1991
16. Craven TE, Ryu JE, Espeland ME, Kahl FR, McKinney WM, Toole JF, McMahan MR, Thompson CJ, Heiss G, Crouse JR: Evaluation of the associations between carotid artery atherosclerosis and coronary artery stenosis: a case-control study. Circulation 82:1230-1242, 1990
17. Folsom AR, Eckfeldt JH, Weitzman S, Ma J, Chambless LE, Barnes RW, Cram KB, Hutchinson RG: Relation of carotid artery wall thickness to diabetes mellitus, fasting glucose and insulin, body size, and physical activity Stroke 25:66-73, 1994
18. Gnasso A, Irace C, Mattioli PL, Pujia A: Carotid intima-media thickness and coronary heart disease risk factors. Atherosclerosis 119:7-15, 1996
19. Gruchow HW Anderson AJ, Barboriak JJ, Sobocinski VA: Postmenopausal use of estrogen and occlusion of coronary arteries. Am Heart J 115:954-963, 1988
20. Howard G, Sharrett AR, Heiss G, Evans GW, Chambless LE, Riley WA, Burke GL: Carotid artery intimal-medial thickness distribution in general populations as evaluated by B-mode ultrasound. Stroke 24:1297-1304, 1993
21. Salonen JT, Salonen R: Ultrasound B-mode imaging in observational studies of atherosclerotic progression (Review). Circulation 87 (Suppl. 3):1156-1165, 1993
22. Burke GL, Evans GW Riley WA, Sharrett AR, Barnes RW Crow RS, Rautaharju PM, Heiss G: Arterial wall thickness is associated with prevalent cardiovascular disease in middle-aged adults: the ARIC study Stroke 26:386-391, 1995
23. Chambless LE, Heiss G, Folsom AR, Rosamond W, Szklo M, Sharrett AR, Clegg LX: Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. Am J Epidemiol 146:483-494, 1997
24. Manolio TA, Furberg C, Shemanski L, Psaty BM, O'Leary DH, Tracy RP, Bush TL: Associations of postmenopausal estrogen use with cardiovascular disease and its risk factors in older women. Circulation 88:2163-2171, 1993
25. Jonas HA, Kronmal RA, Psaty BM, Manolio TA, Meilahn EN, Tell GS, Tracy RP, Robbins JA, Anton-Culver H: Current estrogen-progestin and estrogen replacement therapy in elderly women: association with carotid atherosclerosis. Ann Epidemiol 6:314-323, 1996
26. Espeland MA, Applegate W, Furberg CD, Lefkowitz D, Rice L, Hunninghake D: Estrogen replacement therapy and progression of intimal-medial thickness in the carotid arteries of postmenopausal women. Am J Epidemiol 142:1011-1019, 1995
27. Nabulsi AA, Folsom AR, Szklo M, White A, Higgins M, Heiss G: No association of menopause and hormone replacement therapy with carotid artery intima-media thickness. Circulation 94:1857-1863, 1996
28. Wagenknecht LE, Mayer EJ, Rewers M, Haffner S, Selby J, Borok GM, Henkin L, Howard G, Savage PJ, Saad MF, Bergman RN, Hamman R: The Insulin Resistance Atherosclerosis Study (IRAS): objectives, design, and recruitment results. Ann Epidemiol 5:464-472, 1995
29. Lipid Research Program: Manual of Laboratory Operation, Vol.1: Lipid and Lipoprotein Analysis. Bethesda, MD, Department of Health, Education, and Welfare, 1974
30. Herbert V, Lau K, Gottlieb CW, Bleicher SJ: Coated charcoal immunoassay of insulin. J Clin Endocrinol Metab 25:1375-1384, 1965
31. World Health Organization: Diabetes Mellitus: Report of a WHO Study Group. Geneva, World Health Org., 1985 (Tech. Rep. Ser., no. 727)
32. O'Leary DH, Polak JF, Wolfson SK Jr, Bond MG, Bommer W, Sheth S, Psaty BM, Sharrett AR, Manolio TA, for the CHS Collaborative Research Group: Use of sonography to evaluate carotid atherosclerosis in the elderly: the Cardiovascular Health Study. Stroke 22:1155-1163, 1991
33. Lohman TG, Roche AR, Martorell R (Eds.): Anthropometric Standardization Reference Manual, Abridged ed. Champaign, IL, Human Kinetics, 1991
34. Rose GA, Blackburn H: Cardiovascular Survey Methods, Geneva, World Health Org., 1968 (Monograph Series no. 56)
35. Prineas RJ, Crow RS, Blackburn H: The Minnesota Code Manual of Electrocardiographs Findings: Standards and Procedures for Measurement and Classification. Littleton, MA, John Wright, 1982
36. Robinson JG, Folsom AR, Nabulsi AA, Watson R, Brancati FL, Cai J, for the Atherosclerosis Risk in Communities Study Investigators: Can postmenopausal hormone replacement improve plasma lipids in women with diabetes? Diabetes Care 19:480-485, 1996
37. Howard G, O'Leary DH, Zaccaro D, Haffner S, Rewers M, Hamman R, Selby JB, Saad M, Savage P, Bergman R: Insulin sensitivity and atherosclerosis. Circulation 93:1809-1817, 1996
38. Wagenknecht LE, D'Agostino RB Jr, Savage PJ, O'Leary DH, Saad MF, Haffner SM: Duration of diabetes and carotid wall thickness: the Insulin Resistance Atherosclerosis Study (IRAS). Stroke 28:999-1005, 1997
39. D'Agostino RB Jr, Burke G, O'Leary D, Rewers M, Selby J, Savage PJ, Saad MF, Bergman RN, Howard G, Wagenknecht, LE, Haffner SM: Ethnic differences in carotid wall thickness: the Insulin Resistance Atherosclerosis Study. Stroke 27:1744-1749, 1996
40. Espeland MA, Hoen H, Byington R, Howard G, Riley WA, Furberg CD: Spatial distribution of carotid intimal medial thickness as measured by B-mode ultrasonography. Stroke 25:1812-1819, 1994
41. Barrett-Connor E: Postmenopausal estrogen and prevention bias, Ann Intern Med 115:455-456, 1991